Modafinil in the Treatment of Debilitating Fatigue in Primary Biliary Cirrhosis A Clinical Experience


     Related Videos

     Related Hubpages

    •  Doc. Url:    Embed Code: 

    • PubMed  status
      (0) (0 Votes)
      Views: (1035)   Date: (29-12-08)   Pages: ()
    • Author:  Ian Gan S  de Jongh M  Kaplan MM.  

    • Abstract:  Division of Gastroenterology, Tufts Medical Center, P.O. Box 233, Boston, MA, 02111, USA.

         Related Documents

           Related Groups

             Related Science News

               More on Sciencestage

                 Answers

                 News
            • Grant aimed at improving schizophrenia treatment
              (SACRAMENTO, Calif.) - Michael Minzenberg, a UC Davis psychiatry researcher, has been awarded a prestigious three-year, $200,000 seed grant from the Dana Foundation to study the brains of patients being treated for schizophrenia
            • We must be science's masters, not at its mercy | John Harris
              Recent advances in neuroscience, such as memory manipulation, create compelling ethical dilemmas This week it was reported that soldiers could potentially, in the near future, have their minds plugged directly into weapons systems , and have their learning boosted by neural stimulation. The Royal Society's Brain Waves project on new directions in neuroscience gives us much to reflect on and ...
            • Bullets to beat the enemy within
              ARMY leaders in various countries have trialled compounds that can keep soldiers awake and alert — or send them to sleep
            • Grant will fund study of cognition and schizophrenia
              SACRAMENTO — Michael Minzenberg, a UC Davis psychiatry researcher, has been awarded a prestigious three-year, $200,000 seed grant from the Dana Foundation to study the brains of patients being treated for schizophrenia to determine how additional treatment to improve cognition interacts with antipsychotic medication.
            • Neuroprotection - Drugs, Markets and Companies
              NEW YORK, Feb. 1, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Neuroprotection - Drugs, Markets and Companies http://www.reportlinker.com/p0203546/Neuroprotection---Drugs-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationThis ...
            • How dementia drugs could be used by the military
              Army leaders in various countries have trialled compounds that can keep soldiers awake and alert – or send them to sleep Drugs that reduce anxiety, tiredness and memory loss – all associated with the treatment of dementia – could be used "off-label" as cognitive enhancers by military personnel, according to a Royal Society report . While caffeine and nicotine are used routinely to reduce fatigue ...
            • Immunome Launches $1.5 Million Offering - cbl
              By Bill Murphy WYNNEWOOD, Pa. -- Immunome Inc. has raised $145,000, or nearly a tenth of a $1.50 mil...
            • Alcohol-dependent Americans more likely to seek treatment than South Koreans
              Hazardous alcohol use and depression are among the 10 leading causes of disability and premature death worldwide, according to the World Health Organization. Many low- to middle-income countries have begun to see a steady increase in alcohol use and have entered the early stages of a tobacco epidemic. A study of alcohol use disorders (AUDs), nicotine dependence (ND), and mood and anxiety ...

                 Related on Wikipedia




























             

            Powered free by PHPmotion